Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00003561 · TERMINATED
Trial details
- NCT number
- NCT00003561
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-02-01
- Primary completion
- 2001-10-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.